Suppr超能文献

中国新冠肺炎大流行期间普通人群心理健康症状的患病率及其相关危险因素。

Prevalence of and Risk Factors Associated With Mental Health Symptoms Among the General Population in China During the Coronavirus Disease 2019 Pandemic.

机构信息

Institute of Mental Health, National Clinical Research Center for Mental Disorders, Key Laboratory of Mental Health and Peking University Sixth Hospital, Peking University, Beijing, China.

Savaid Medical School, University of Chinese Academy of Sciences, Beijing, China.

出版信息

JAMA Netw Open. 2020 Jul 1;3(7):e2014053. doi: 10.1001/jamanetworkopen.2020.14053.

Abstract

IMPORTANCE

People exposed to coronavirus disease 2019 (COVID-19) and a series of imperative containment measures could be psychologically stressed, yet the burden of and factors associated with mental health symptoms remain unclear.

OBJECTIVE

To investigate the prevalence of and risk factors associated with mental health symptoms in the general population in China during the COVID-19 pandemic.

DESIGN, SETTING, AND PARTICIPANTS: This large-sample, cross-sectional, population-based, online survey study was conducted from February 28, 2020, to March 11, 2020. It involved all 34 province-level regions in China and included participants aged 18 years and older. Data analysis was performed from March to May 2020.

MAIN OUTCOMES AND MEASURES

The prevalence of symptoms of depression, anxiety, insomnia, and acute stress among the general population in China during the COVID-19 pandemic was evaluated using the Patient Health Questionnaire-9, Generalized Anxiety Disorder-7, Insomnia Severity Index, and Acute Stress Disorder Scale. Logistic regression analyses were used to explore demographic and COVID-19-related risk factors.

RESULTS

Of 71 227 individuals who clicked on the survey link, 56 932 submitted the questionnaires, for a participation rate of 79.9%. After excluding the invalid questionnaires, 56 679 participants (mean [SD] age, 35.97 [8.22] years; 27 149 men [47.9%]) were included in the study; 39 468 respondents (69.6%) were aged 18 to 39 years. During the COVID-19 pandemic, the rates of mental health symptoms among the survey respondents were 27.9% (95% CI, 27.5%-28.2%) for depression, 31.6% (95% CI, 31.2%-32.0%) for anxiety, 29.2% (95% CI, 28.8%-29.6%) for insomnia, and 24.4% (95% CI, 24.0%-24.7%) for acute stress. Participants with confirmed or suspected COVID-19 and their family members or friends had a high risk for symptoms of depression (adjusted odds ratios [ORs], 3.27 [95% CI, 1.84-5.80] for patients; 1.53 [95% CI, 1.26-1.85] for family or friends), anxiety (adjusted ORs, 2.48 [95% CI, 1.43-4.31] for patients; 1.53 [95% CI, 1.27-1.84] for family or friends), insomnia (adjusted ORs, 3.06 [95% CI, 1.73-5.43] for patients; 1.62 [95% CI, 1.35-1.96] for family or friends), and acute stress (adjusted ORs, 3.50 [95% CI, 2.02-6.07] for patients; 1.77 [95% CI, 1.46-2.15] for family or friends). Moreover, people with occupational exposure risks and residents in Hubei province had increased odds of symptoms of depression (adjusted ORs, 1.96 [95% CI, 1.77-2.17] for occupational exposure; 1.42 [95% CI, 1.19-1.68] for Hubei residence), anxiety (adjusted ORs, 1.93 [95% CI, 1.75-2.13] for occupational exposure; 1.54 [95% CI, 1.30-1.82] for Hubei residence), insomnia (adjusted ORs, 1.60 [95% CI, 1.45-1.77] for occupational exposure; 1.20 [95% CI, 1.01-1.42] for Hubei residence), and acute stress (adjusted ORs, 1.98 [95% CI, 1.79-2.20] for occupational exposure; 1.49 [95% CI, 1.25-1.79] for Hubei residence). Both centralized quarantine (adjusted ORs, 1.33 [95% CI, 1.10-1.61] for depression; 1.46 [95% CI, 1.22-1.75] for anxiety; 1.63 [95% CI, 1.36-1.95] for insomnia; 1.46 [95% CI, 1.21-1.77] for acute stress) and home quarantine (adjusted ORs, 1.30 [95% CI, 1.25-1.36] for depression; 1.28 [95% CI, 1.23-1.34] for anxiety; 1.24 [95% CI, 1.19-1.30] for insomnia; 1.29 [95% CI, 1.24-1.35] for acute stress) were associated with the 4 negative mental health outcomes. Being at work was associated with lower risks of depression (adjusted OR, 0.85 [95% CI, 0.79-0.91]), anxiety (adjusted OR, 0.92 [95% CI, 0.86-0.99]), and insomnia (adjusted OR, 0.87 [95% CI, 0.81-0.94]).

CONCLUSIONS AND RELEVANCE

The results of this survey indicate that mental health symptoms may have been common during the COVID-19 outbreak among the general population in China, especially among infected individuals, people with suspected infection, and people who might have contact with patients with COVID-19. Some measures, such as quarantine and delays in returning to work, were also associated with mental health among the public. These findings identify populations at risk for mental health problems during the COVID-19 pandemic and may help in implementing mental health intervention policies in other countries and regions.

摘要

重要性

接触冠状病毒病 2019(COVID-19)和一系列强制性遏制措施的人可能会承受心理压力,但精神健康症状的负担和相关因素仍不清楚。

目的

调查 COVID-19 大流行期间中国普通人群精神健康症状的流行率和相关风险因素。

设计、地点和参与者:这是一项大型的、横断面的、基于人群的在线调查研究,于 2020 年 2 月 28 日至 3 月 11 日进行,涉及中国所有 34 个省级行政区,参与者年龄在 18 岁及以上。数据分析于 2020 年 3 月至 5 月进行。

主要结果和措施

使用患者健康问卷-9、广泛性焦虑障碍-7、失眠严重程度指数和急性应激障碍量表评估 COVID-19 大流行期间中国普通人群中抑郁、焦虑、失眠和急性应激症状的发生率。使用 logistic 回归分析探讨人口统计学和 COVID-19 相关的风险因素。

结果

在点击调查链接的 71227 人中,56932 人提交了问卷,参与率为 79.9%。排除无效问卷后,56679 名参与者(平均[SD]年龄,35.97[8.22]岁;27149 名男性[47.9%])被纳入研究;39468 名受访者(69.6%)年龄在 18 至 39 岁之间。在 COVID-19 大流行期间,调查对象的精神健康症状发生率为:抑郁症状 27.9%(95%CI,27.5%-28.2%),焦虑症状 31.6%(95%CI,31.2%-32.0%),失眠症状 29.2%(95%CI,28.8%-29.6%),急性应激症状 24.4%(95%CI,24.0%-24.7%)。确诊或疑似 COVID-19 患者及其家庭成员或朋友患抑郁(调整后的优势比[ORs],1.84-5.80)、焦虑(调整后的 ORs,1.26-1.85)、失眠(调整后的 ORs,1.35-1.96)和急性应激(调整后的 ORs,1.46-2.15)的风险较高。此外,有职业暴露风险的人群和居住在湖北省的人群患抑郁(调整后的 ORs,1.77-2.15)、焦虑(调整后的 ORs,1.54-1.82)、失眠(调整后的 ORs,1.20-1.42)和急性应激(调整后的 ORs,1.49-1.79)的风险也较高。集中隔离(调整后的 ORs,1.33-1.61)和居家隔离(调整后的 ORs,1.30-1.77)也与抑郁、焦虑、失眠和急性应激有关。工作时患抑郁(调整后的 OR,0.85-0.91)、焦虑(调整后的 OR,0.86-0.99)和失眠(调整后的 OR,0.81-0.94)的风险较低。

结论和相关性

这项调查的结果表明,COVID-19 大流行期间中国普通人群的精神健康症状可能较为常见,尤其是感染人群、疑似感染人群以及可能与 COVID-19 患者接触的人群。一些措施,如隔离和延迟复工,也与公众的精神健康有关。这些发现确定了 COVID-19 大流行期间精神健康问题的高风险人群,并可能有助于在其他国家和地区实施精神健康干预政策。

相似文献

2
Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019.
JAMA Netw Open. 2020 Mar 2;3(3):e203976. doi: 10.1001/jamanetworkopen.2020.3976.
4
[Stress, anxiety, depression and insomnia in adults outside Hubei province during the COVID-19 pandemic].
Zhonghua Yi Xue Za Zhi. 2020 Nov 24;100(43):3419-3424. doi: 10.3760/cma.j.cn112137-20200302-00557.
5
Factors Associated With Mental Health Disorders Among University Students in France Confined During the COVID-19 Pandemic.
JAMA Netw Open. 2020 Oct 1;3(10):e2025591. doi: 10.1001/jamanetworkopen.2020.25591.
8
Sleep problems among Chinese adolescents and young adults during the coronavirus-2019 pandemic.
Sleep Med. 2020 Oct;74:39-47. doi: 10.1016/j.sleep.2020.06.001. Epub 2020 Jun 6.

引用本文的文献

1
Traditional Chinese medicine therapies for insomnia: An umbrella review and evidence map.
Integr Med Res. 2025 Sep;14(3):101176. doi: 10.1016/j.imr.2025.101176. Epub 2025 Jun 1.
2
Loneliness and depression among men in Poland: cross-sectional study.
Front Public Health. 2025 Jun 17;13:1539822. doi: 10.3389/fpubh.2025.1539822. eCollection 2025.
3
A guided internet-delivered mindfulness-based cognitive therapy for insomnia: study protocol for a randomized controlled study.
Front Psychiatry. 2025 May 27;16:1506183. doi: 10.3389/fpsyt.2025.1506183. eCollection 2025.
5
Anxiety relief in the post-pandemic era: a randomized trial on the integration of digital technology into dance art healing.
Front Psychol. 2025 May 22;16:1545461. doi: 10.3389/fpsyg.2025.1545461. eCollection 2025.
6
The improvement path of depression and anxiety among adult women in Shanxi Province, China: a fuzzy-set qualitative comparative analysis.
Front Public Health. 2025 May 15;13:1531431. doi: 10.3389/fpubh.2025.1531431. eCollection 2025.
7
The Impact of Omicron-related Stress on Mental Health in the General Population of China.
Actas Esp Psiquiatr. 2025 May;53(3):464-475. doi: 10.62641/aep.v53i3.1831.

本文引用的文献

2
A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations.
Gen Psychiatr. 2020 Mar 6;33(2):e100213. doi: 10.1136/gpsych-2020-100213. eCollection 2020.
4
Covid-19 and community mitigation strategies in a pandemic.
BMJ. 2020 Mar 17;368:m1066. doi: 10.1136/bmj.m1066.
6
COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis.
J Med Virol. 2020 Jun;92(6):577-583. doi: 10.1002/jmv.25757. Epub 2020 Mar 23.
8
Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV.
Eur Rev Med Pharmacol Sci. 2020 Feb;24(4):2012-2019. doi: 10.26355/eurrev_202002_20379.
9
Priorities for the US Health Community Responding to COVID-19.
JAMA. 2020 Apr 14;323(14):1343-1344. doi: 10.1001/jama.2020.3413.
10
The psychological impact of quarantine and how to reduce it: rapid review of the evidence.
Lancet. 2020 Mar 14;395(10227):912-920. doi: 10.1016/S0140-6736(20)30460-8. Epub 2020 Feb 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验